title: Interplay between p53 and VEGF: how to prevent the guardian from becoming a villain.
authors.forename: S
authors.initials: S
authors.lastname: Haupt
authors.forename: C
authors.initials: C
authors.lastname: Gamell
authors.forename: K
authors.initials: K
authors.lastname: Wolyniec
authors.forename: Y
authors.initials: Y
authors.lastname: Haupt
mesh_terms: D000818:Animals; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism*; D006801:Humans; D000860:Hypoxia / Q000378:metabolism*; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D016160:Retinoblastoma Protein / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
chemical_list: D050759:Cyclin-Dependent Kinase Inhibitor p21; D016160:Retinoblastoma Protein; D016159:Tumor Suppressor Protein p53; D042461:Vascular Endothelial Growth Factor A